Here are the DEF 14A proxy statements from Fulgent Genetics, Inc. (FLGT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow FLGT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FLGT filings page.
Fulgent Genetics, Inc. is asking stockholders to vote at its 2026 Annual Meeting on May 14, 2026 at 9:00 a.m. Pacific Time in El Monte, California. Investors will elect four directors for one-year terms, ratify Deloitte & Touche LLP as auditor for 2026, cast an advisory vote on named executive officer pay, and vote on the new 2026 Equity Incentive Plan. The proxy details ownership levels, with directors and executive officers as a group holding a significant stake, outlines board committee structure and independence, and explains the company’s pay-for-performance philosophy, risk controls, and cybersecurity and sustainability oversight.